Since this dysfunction might not be restored by anti-PD-L1 or anti-PD-1 alone, additional strategies including cytokines such as IL-2 might be synergistic in boosting the anti-tumor immunity of liver CD8+ TRM cells surrounding HCC (Figure 2). The gene discussed is CD8A; the disease is neoplasm.